| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| ENSCVAP00000030679 | LOC107086777 | ENSCVAP00000030679 | ENSCVAP00000024084 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor substrate 2a. | 0.952 |
| ENSCVAP00000030679 | LOC107087768 | ENSCVAP00000030679 | ENSCVAP00000004232 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Si:ch73-335l21.1. | 0.952 |
| ENSCVAP00000030679 | LOC107091522 | ENSCVAP00000030679 | ENSCVAP00000011000 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor substrate 4a. | 0.952 |
| ENSCVAP00000030679 | LOC107091852 | ENSCVAP00000030679 | ENSCVAP00000031840 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Uncharacterized protein. | 0.471 |
| ENSCVAP00000030679 | LOC107094114 | ENSCVAP00000030679 | ENSCVAP00000032307 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Growth factor receptor-bound protein 10b. | 0.471 |
| ENSCVAP00000030679 | grb2 | ENSCVAP00000030679 | ENSCVAP00000009535 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Growth factor receptor-bound protein 2b. | 0.598 |
| ENSCVAP00000030679 | igf1 | ENSCVAP00000030679 | ENSCVAP00000028775 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin-like growth factor 1. | 0.946 |
| ENSCVAP00000030679 | igf1r | ENSCVAP00000030679 | ENSCVAP00000001583 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Tyrosine-protein kinase receptor. | 0.980 |
| ENSCVAP00000030679 | ins | ENSCVAP00000030679 | ENSCVAP00000028143 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.900 |
| ENSCVAP00000030679 | irs2 | ENSCVAP00000030679 | ENSCVAP00000029130 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor substrate 2b. | 0.952 |
| LOC107086777 | ENSCVAP00000030679 | ENSCVAP00000024084 | ENSCVAP00000030679 | Insulin receptor substrate 2a. | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.952 |
| LOC107086777 | grb2 | ENSCVAP00000024084 | ENSCVAP00000009535 | Insulin receptor substrate 2a. | Growth factor receptor-bound protein 2b. | 0.981 |
| LOC107086777 | igf1 | ENSCVAP00000024084 | ENSCVAP00000028775 | Insulin receptor substrate 2a. | Insulin-like growth factor 1. | 0.445 |
| LOC107086777 | igf1r | ENSCVAP00000024084 | ENSCVAP00000001583 | Insulin receptor substrate 2a. | Tyrosine-protein kinase receptor. | 0.976 |
| LOC107086777 | ins | ENSCVAP00000024084 | ENSCVAP00000028143 | Insulin receptor substrate 2a. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.952 |
| LOC107087768 | ENSCVAP00000030679 | ENSCVAP00000004232 | ENSCVAP00000030679 | Si:ch73-335l21.1. | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.952 |
| LOC107087768 | grb2 | ENSCVAP00000004232 | ENSCVAP00000009535 | Si:ch73-335l21.1. | Growth factor receptor-bound protein 2b. | 0.981 |
| LOC107087768 | igf1 | ENSCVAP00000004232 | ENSCVAP00000028775 | Si:ch73-335l21.1. | Insulin-like growth factor 1. | 0.445 |
| LOC107087768 | igf1r | ENSCVAP00000004232 | ENSCVAP00000001583 | Si:ch73-335l21.1. | Tyrosine-protein kinase receptor. | 0.973 |
| LOC107087768 | ins | ENSCVAP00000004232 | ENSCVAP00000028143 | Si:ch73-335l21.1. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.952 |